Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KCNC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LFNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CRHR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101930415 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
LOC100129726 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRNP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKFY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM74 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXXC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALPI - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIKFYVE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAZN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on